Health Insurance Agents and Marketers. Health Insurance web Directory: Dental Insurance, Disability Insurance, Discount Plans and quotes, Long Term Care Health Insurance, Medical Savings Accounts - all Health insurance information in one searchable Directory. List of companies offering health insurance to individuals and businesses, information on the kinds of health insurance by product, services or company.
Choose Your Health Benefits
Individual and family health insurance plans. Online sign-up, a dictionary, and online tools to manage health benefits.
Nationally available group health insurance and medical employee benefit plans.
Advisors Health Insurance
Health insurance agency offering free quotes and enrollment services for most plans offered in Arizona.
Health Care Now
Specializing in health insurance and long term care solutions to individuals and groups. Los Angeles, CA.
Health benefits brokerage that designs, implements and manages progressive health care plans for corporations nationwide.
Study says many lung cancer tumors prove harmless
Pa. students' robotic arm can make you stronger
CHICAGO (AP) — Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems.
Health care debate has trust, politics themes, too
PHILADELPHIA (AP) — Need a hand lifting something? A robotic device invented by University of Pennsylvania engineering students can help its wearer carry an additional 40 pounds.
Police probe Novo Nordisk for late disclosure of drug setback
WASHINGTON (AP) — For months, the talk was all about computer code. About response times. About glitches and bugs.
By Shida Chayesteh COPENHAGEN (Reuters) - Novo Nordisk, the world's largest insulin maker, has been reported to the police by Denmark's financial watchdog for not disclosing at once that its big new product hope Tresiba had been refused U.S. approval. The Danish Financial Supervisory Authority (FSA) said the company should have issued a statement about the U.S. decision not to approve its new long-acting insulin on the evening of Friday, February 8, and not wait until Sunday, February 10, as it did. The news that the Food and Drug Administration (FDA) had declined to approve Tresiba and a related combination drug called Ryzodeg was a major blow to Novo and confounded expectations of investors, who had expected a green light. The drugmaker argues that even if the disclosure obligation applied from Friday evening - the time it received the bad news from the FDA - it was still entitled to delay an announcement until it had analyzed the implications.